HUT77925A - Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra - Google Patents
Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukraInfo
- Publication number
- HUT77925A HUT77925A HU9700022A HU9700022A HUT77925A HU T77925 A HUT77925 A HU T77925A HU 9700022 A HU9700022 A HU 9700022A HU 9700022 A HU9700022 A HU 9700022A HU T77925 A HUT77925 A HU T77925A
- Authority
- HU
- Hungary
- Prior art keywords
- pct
- dihydrobenzofuranes
- producing
- active agents
- pharmaceuticals containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH232394 | 1994-07-22 | ||
PCT/EP1995/002841 WO1996003399A1 (de) | 1994-07-22 | 1995-07-19 | Dihydrobenzofurane |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9700022D0 HU9700022D0 (en) | 1997-02-28 |
HUT77925A true HUT77925A (hu) | 1998-11-30 |
HU221504B HU221504B (en) | 2002-10-28 |
Family
ID=4231132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9700022A HU221504B (en) | 1994-07-22 | 1995-07-19 | Dihydrobenzofuranes |
Country Status (22)
Country | Link |
---|---|
US (1) | US6121274A (hu) |
EP (1) | EP0772610B9 (hu) |
JP (1) | JP4146894B2 (hu) |
KR (1) | KR100381584B1 (hu) |
CN (1) | CN1068879C (hu) |
AT (1) | ATE196765T1 (hu) |
AU (1) | AU702346B2 (hu) |
CZ (1) | CZ291758B6 (hu) |
DE (1) | DE59508773D1 (hu) |
DK (1) | DK0772610T3 (hu) |
ES (1) | ES2152414T3 (hu) |
FI (1) | FI970246A0 (hu) |
GR (1) | GR3034991T3 (hu) |
HU (1) | HU221504B (hu) |
MX (1) | MX9700557A (hu) |
NO (1) | NO311221B1 (hu) |
NZ (1) | NZ290420A (hu) |
PL (1) | PL185683B1 (hu) |
PT (1) | PT772610E (hu) |
RU (1) | RU2138498C1 (hu) |
SK (1) | SK281857B6 (hu) |
WO (1) | WO1996003399A1 (hu) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0771794B1 (en) * | 1995-05-19 | 2006-05-03 | Kyowa Hakko Kogyo Co., Ltd. | Oxygen-containing heterocyclic compounds |
US6514996B2 (en) | 1995-05-19 | 2003-02-04 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of benzofuran or benzodioxole |
CA2238376C (en) * | 1995-12-05 | 2006-08-15 | Darwin Discovery Limited | Benzofuran carboxamides and sulphonamides |
JP2000510134A (ja) * | 1996-05-15 | 2000-08-08 | ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規のイミダゾピリジン |
ATE239004T1 (de) * | 1996-05-20 | 2003-05-15 | Darwin Discovery Ltd | Benzofuran carboxamide und ihre therapeutische anwendung |
DE19628621A1 (de) * | 1996-07-16 | 1998-01-22 | Byk Gulden Lomberg Chem Fab | Neue 4-substituierte Benzofurane |
DE19628622A1 (de) * | 1996-07-16 | 1998-01-22 | Byk Gulden Lomberg Chem Fab | Neue 5-substituierte [2H] Chromene |
DK0923568T5 (da) * | 1996-08-19 | 2003-11-03 | Altana Pharma Ag | Hidtil ukendte benzofuran-4-carboxamider |
JP2001504462A (ja) * | 1996-11-12 | 2001-04-03 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | ホスホジエステラーゼ阻害剤としての(2,3―ジヒドロベンゾフラニル)―チアゾール |
ES2193414T3 (es) * | 1996-11-20 | 2003-11-01 | Altana Pharma Ag | Dihidrobenzofuranos sustituidos como inhibidores de la pde. |
WO1999031090A1 (en) * | 1997-12-15 | 1999-06-24 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Dihydrobenzofurans |
GB2333041A (en) * | 1998-01-13 | 1999-07-14 | Johnson & Johnson Medical Ltd | Wound Composition |
ES2201712T3 (es) * | 1998-05-05 | 2004-03-16 | Altana Pharma Ag | Nuevos bencimidazoles y benzoxazoles. |
EP1086096B1 (de) * | 1998-06-10 | 2003-07-23 | ALTANA Pharma AG | Benzamide mit tetrahydrofuranyloxy-substituenten als inhibitoren der phosphodiesterase 4 |
HU229439B1 (hu) | 1999-08-21 | 2013-12-30 | Takeda Gmbh | Roflumilast és salmeterol szinergetikus kombinációja |
GB0003257D0 (en) | 2000-02-11 | 2000-04-05 | Darwin Discovery Ltd | Heterocyclic compounds and their therapeutic use |
CN1646118A (zh) * | 2002-03-29 | 2005-07-27 | 中外制药株式会社 | 预防或治疗呼吸系统疾病的药物组合物 |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
CN101300243A (zh) * | 2005-11-04 | 2008-11-05 | 日本曹达株式会社 | 邻位取代苯胺衍生物和抗氧化药 |
US7842713B2 (en) * | 2006-04-20 | 2010-11-30 | Pfizer Inc | Fused phenyl amido heterocyclic compounds |
ES2374337T3 (es) | 2007-05-16 | 2012-02-15 | Nycomed Gmbh | Derivados de pirazolona como inhibidores de pde4. |
US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
GEP20135793B (en) | 2008-09-11 | 2013-03-25 | Pfizer | Heteroaryls amide derivatives and their use as glucokinase activators |
PT2406253E (pt) * | 2009-03-11 | 2013-09-11 | Pfizer | Derivados de benzofuranilo utilizados como inibidores de glucocinase |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
MX357121B (es) | 2011-03-01 | 2018-06-27 | Synergy Pharmaceuticals Inc Star | Proceso de preparacion de agonistas c de guanilato ciclasa. |
WO2013104257A1 (zh) * | 2012-01-12 | 2013-07-18 | 江苏恒瑞医药股份有限公司 | 多环类衍生物、其制备方法及其在医药上的应用 |
US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
EP3004138B1 (en) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
JP6694385B2 (ja) | 2013-08-09 | 2020-05-13 | アーデリクス,インコーポレーテッド | リン酸塩輸送阻害のための化合物及び方法 |
TWI828952B (zh) | 2015-06-05 | 2024-01-11 | 美商艾佛艾姆希公司 | 作為除草劑之嘧啶氧基苯衍生物 |
US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE71647B1 (en) * | 1991-01-28 | 1997-02-26 | Rhone Poulenc Rorer Ltd | Benzamide derivatives |
ATE150447T1 (de) * | 1992-06-15 | 1997-04-15 | Celltech Therapeutics Ltd | Trisubstituierte phenylderivate als selektive phosphodiesterase iv inhibitoren |
GB9212693D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
-
1995
- 1995-07-19 KR KR1019970700420A patent/KR100381584B1/ko not_active IP Right Cessation
- 1995-07-19 PT PT95926953T patent/PT772610E/pt unknown
- 1995-07-19 RU RU97102828A patent/RU2138498C1/ru not_active IP Right Cessation
- 1995-07-19 US US08/750,920 patent/US6121274A/en not_active Expired - Lifetime
- 1995-07-19 SK SK2-97A patent/SK281857B6/sk not_active IP Right Cessation
- 1995-07-19 WO PCT/EP1995/002841 patent/WO1996003399A1/de active IP Right Grant
- 1995-07-19 MX MX9700557A patent/MX9700557A/es not_active IP Right Cessation
- 1995-07-19 NZ NZ290420A patent/NZ290420A/xx not_active IP Right Cessation
- 1995-07-19 EP EP95926953A patent/EP0772610B9/de not_active Expired - Lifetime
- 1995-07-19 CN CN95195177A patent/CN1068879C/zh not_active Expired - Fee Related
- 1995-07-19 JP JP50543996A patent/JP4146894B2/ja not_active Expired - Lifetime
- 1995-07-19 CZ CZ1997188A patent/CZ291758B6/cs not_active IP Right Cessation
- 1995-07-19 ES ES95926953T patent/ES2152414T3/es not_active Expired - Lifetime
- 1995-07-19 PL PL95318297A patent/PL185683B1/pl not_active IP Right Cessation
- 1995-07-19 DK DK95926953T patent/DK0772610T3/da active
- 1995-07-19 AU AU31153/95A patent/AU702346B2/en not_active Ceased
- 1995-07-19 HU HU9700022A patent/HU221504B/hu not_active IP Right Cessation
- 1995-07-19 DE DE59508773T patent/DE59508773D1/de not_active Expired - Lifetime
- 1995-07-19 AT AT95926953T patent/ATE196765T1/de not_active IP Right Cessation
-
1997
- 1997-01-09 NO NO19970092A patent/NO311221B1/no not_active IP Right Cessation
- 1997-01-21 FI FI970246A patent/FI970246A0/fi unknown
-
2000
- 2000-12-05 GR GR20000402680T patent/GR3034991T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NZ290420A (en) | 1999-01-28 |
AU702346B2 (en) | 1999-02-18 |
EP0772610A1 (de) | 1997-05-14 |
HU221504B (en) | 2002-10-28 |
MX9700557A (es) | 1997-12-31 |
RU2138498C1 (ru) | 1999-09-27 |
FI970246A (fi) | 1997-01-21 |
JP4146894B2 (ja) | 2008-09-10 |
SK297A3 (en) | 1997-08-06 |
CN1159804A (zh) | 1997-09-17 |
JPH10503484A (ja) | 1998-03-31 |
ATE196765T1 (de) | 2000-10-15 |
AU3115395A (en) | 1996-02-22 |
FI970246A0 (fi) | 1997-01-21 |
CZ18897A3 (en) | 1997-09-17 |
DK0772610T3 (da) | 2001-01-29 |
CZ291758B6 (cs) | 2003-05-14 |
US6121274A (en) | 2000-09-19 |
GR3034991T3 (en) | 2001-03-30 |
NO311221B1 (no) | 2001-10-29 |
PL318297A1 (en) | 1997-06-09 |
PL185683B1 (pl) | 2003-07-31 |
NO970092D0 (no) | 1997-01-09 |
SK281857B6 (sk) | 2001-08-06 |
KR100381584B1 (ko) | 2003-08-21 |
DE59508773D1 (de) | 2000-11-09 |
WO1996003399A1 (de) | 1996-02-08 |
EP0772610B9 (de) | 2001-07-25 |
ES2152414T3 (es) | 2001-02-01 |
NO970092L (no) | 1997-01-09 |
EP0772610B1 (de) | 2000-10-04 |
CN1068879C (zh) | 2001-07-25 |
HU9700022D0 (en) | 1997-02-28 |
PT772610E (pt) | 2001-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT77925A (hu) | Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra | |
BG103485A (en) | Ketobanzamides as calpain inhibitors | |
TW263499B (hu) | ||
ZA959451B (en) | 2,2-Dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these | |
GR3035744T3 (en) | N-substituted azabicycloheptane derivatives useful as neuroleptics | |
AU3473595A (en) | Novel phosphane oxides, method of preparing them and drugs containing these compounds | |
KR960700223A (ko) | C-치환 디에틸렌 트리아민의 제조 방법(Process for the Production of C-Substituted Diethylenetriamines) | |
ATE207480T1 (de) | Substituierte aminoalkylaminopyridine | |
ZA955052B (en) | Pyrrolidine derivatives their preparation and compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB9A | Succession in title |
Owner name: ALTANA PHARMA AG, DE Free format text: FORMER OWNER(S): BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH., DE |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |